Newland Pharmaceutical Co., Ltd. Share Price

Equities

301277

CNE1000065K2

Pharmaceuticals

End-of-day quote Shenzhen S.E. 03:30:00 26/06/2024 am IST 5-day change 1st Jan Change
13.4 CNY +3.08% Intraday chart for Newland Pharmaceutical Co., Ltd. -3.60% -9.85%

Financials

Sales 2022 63Cr 8.63Cr 721.39Cr Sales 2023 65Cr 8.97Cr 749.07Cr Capitalization 416.28Cr 57Cr 4.79TCr
Net income 2022 13Cr 1.82Cr 151.78Cr Net income 2023 16Cr 2.19Cr 182.83Cr EV / Sales 2022 4.95 x
Net cash position 2022 75Cr 10Cr 858.69Cr Net cash position 2023 86Cr 12Cr 985.21Cr EV / Sales 2023 5.07 x
P/E ratio 2022
22.4 x
P/E ratio 2023
26.3 x
Employees 1,010
Yield 2022
1.73%
Yield 2023
1.92%
Free-Float 21.38%
More Fundamentals * Assessed data
Dynamic Chart
1 day+3.08%
1 week-3.60%
Current month-8.59%
1 month-13.27%
3 months+2.12%
6 months-6.57%
Current year-9.85%
More quotes
1 week
12.86
Extreme 12.86
14.11
1 month
12.86
Extreme 12.86
15.09
Current year
9.30
Extreme 9.3
18.38
1 year
9.30
Extreme 9.3
22.49
3 years
9.30
Extreme 9.3
24.76
5 years
9.30
Extreme 9.3
24.76
10 years
9.30
Extreme 9.3
24.76
More quotes
Date Price Change Volume
26/24/26 13.4 +3.08% 3,816,200
25/24/25 13 -0.23% 3,071,420
24/24/24 13.03 -4.89% 5,445,596
21/24/21 13.7 +0.37% 5,735,628
20/24/20 13.65 -1.80% 9,957,876

End-of-day quote Shenzhen S.E., June 26, 2024

More quotes
Newland Pharmaceutical Co Ltd, formerly Henan Newland Pharmaceutical Co Ltd, is a China-based company mainly engaged in pharmaceutical research and development. The Company's main business is the research and development, production and sales of pharmaceutical intermediates. The Company's main products are L-p-hydroxyphenylglycine series products and p-toluenesulfonic acid, including D-acid, methyl ester and hydroxydeng salt. The Company also produces pharmaceutical resolution agents. The Company mainly operates its businesses in the domestic and overseas markets.
More about the company
  1. Stock Market
  2. Equities
  3. 301277 Stock